NCT05972733View on ClinicalTrials.gov

Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 14, 2023

Study Completion Date

November 10, 2023

Conditions

Gastroenteritis

Interventions

BIOLOGICAL

HIL-214

HIL-214

Trial Locations (2)

30281

Clinical Research Atlanta, Stockbridge

90274

Pennisula Research Associates, Rolling Hills Estates

Sponsors

Lead Sponsor

All Listed Sponsors

lead

HilleVax

INDUSTRY